Waterford

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa3 trials
• Macular degeneration1 trial

Phase

• Phase 34 trials

Status

• Completed3 trials
• Enrolling by invitation1 trial

Lead sponsor

• MoonLake Immunotherapeutics AG3 trials
• Outlook Therapeutics, Inc.1 trial

Running trials

• Enrolling by invitation

  A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT07007637· Phase 3· MoonLake Immunotherapeutics AG· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa1 recruiting

Closed trials

• Completed

  An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

  NCT06768671· Phase 3· MoonLake Immunotherapeutics AG· Source

• Completed

  Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06411379· Phase 3· MoonLake Immunotherapeutics AG· Source

• Completed

  A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

  NCT06190093· Phase 3· Outlook Therapeutics, Inc.· Source